TÜRK, C. Et Al. 2019. The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.2 , 661-674.

TÜRK, C., Okay, M., TÜRK, S., Temirci, E. S., Javad, O., AKSU, S., ... SAYINALP, N.(2019). The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.2, 661-674.

TÜRK, CAN Et Al. "The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.2, 661-674, 2019

TÜRK, CAN Et Al. "The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.2, pp.661-674, 2019

TÜRK, C. Et Al. (2019) . "The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.2, pp.661-674.

@article{article, author={CAN TÜRK Et Al. }, title={The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2019, pages={661-674} }